Hyacinth Deblocking Reagent – 3% DCA in Toluene

Price range: €119.00 through €171.00

Hyacinth Deblocking Reagent with 3% dichloroacetic acid in toluene. A gentle, high-purity solution for 5’-DMT removal in oligonucleotide synthesis workflows.

Download Oligonucleotide Synthesis Reagents Catalogue (PDF)

  • kr.
  • kr
  • kr
  • kr.

Description

Hyacinth Deblocking Reagent – 3% Dichloroacetic Acid in Toluene for DNA/RNA Synthesis

Hyacinth Deblocking Reagent is a 3% (v/v) solution of dichloroacetic acid (DCA) in toluene, formulated for gentle and precise deblocking in phosphoramidite-based oligonucleotide synthesis. Used during the detritylation step, this reagent efficiently removes the 5’-DMT protecting group without overexposure or degradation of sensitive sequences.

With a lower acid concentration than standard 10% DCA solutions, Hyacinth is particularly suited for protocols where reaction control, milder conditions, or higher synthesis fidelity is essential — including long oligos or modified bases.

Key Features:

  • 3% dichloroacetic acid (DCA) in toluene
  • Low-strength deblocking for 5’-DMT removal
  • High-purity formulation for DNA and RNA synthesis
  • Compatible with both manual and automated synthesizers
  • Ideal for sensitive or high-precision oligo synthesis

Applications:

  • Deblocking step in oligonucleotide synthesis
  • Detritylation under mild conditions
  • Long or modified oligo workflows
  • DNA/RNA synthesis requiring slower DMT removal

Distribution:

  • Available across Denmark, Sweden, Norway, and Iceland
  • Fast delivery and expert support from YouDoBio

Additional information

pack-size

,

You Do Bio

At You Do Bio, our interest is in bringing great lab technology to scientists. Great tools, together with great minds, make great science possible.

+45 25 57 38 76

info@youdobio.pilardev.fi

Hendriksholms Boulevard 59 2610 Rødovre – Denmark

© 2025 You Do Bio - All rights reserved

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept